Literature DB >> 21308454

Current Views on the Pathophysiology of GB Virus C Coinfection with HIV-1 Infection.

Esaki Muthu Shankar1, Pachamuthu Balakrishnan, Ramachandran Vignesh, Vijayakumar Velu, Palanisamy Jayakumar, Suniti Solomon.   

Abstract

GB virus C (GBV-C), a member of the Flaviviridae family of viruses, recently received considerable attention largely owing to its potential role in decelerating HIV-1 disease progression by interfering with HIV replication. With similar transmission features, GBV-C is parenterally transmitted, similar to the serum hepatitis viruses and HIV-1, and replicates in hemopoietic cells and T lymphocytes in particular, with no observable disease pathology. Progressive T-cell depletion and subsequent immune abrogation being the cardinal features of HIV-1 infection, accumulating evidence indicates that GBV-C effectively overturns HIV's chances of exploiting the T-cell machinery and leads to enhanced survival rates of HIV-infected subjects. Much effort has been devoted to understanding the beneficial role of GBV-C in HIV disease. This review discusses recently proposed mechanisms underlying the pathophysiology of GBV-C coinfection in HIV disease.

Entities:  

Year:  2011        PMID: 21308454     DOI: 10.1007/s11908-010-0142-z

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  50 in total

1.  Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team.

Authors:  M J Alter; M Gallagher; T T Morris; L A Moyer; E L Meeks; K Krawczynski; J P Kim; H S Margolis
Journal:  N Engl J Med       Date:  1997-03-13       Impact factor: 91.245

2.  Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons.

Authors:  J J Lefrère; F Roudot-Thoraval; L Morand-Joubert; J C Petit; J Lerable; M Thauvin; M Mariotti
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

3.  Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals.

Authors:  Giorgio Antonucci; Enrico Girardi; Alessandro Cozzi-Lepri; Maria Rosaria Capobianchi; Giulia Morsica; Paolo Pizzaferri; Nicoletta Ladisa; Laura Sighinolfi; Alessandro Chiodera; Mariacarmela Solmone; Eleonora Lalle; Giuseppe Ippolito; Antonella d'Arminio Monforte
Journal:  Antivir Ther       Date:  2005

4.  Sexual transmission of GB virus C/hepatitis G virus.

Authors:  M F Scallan; D Clutterbuck; L M Jarvis; G R Scott; P Simmonds
Journal:  J Med Virol       Date:  1998-07       Impact factor: 2.327

5.  Activation of interferon response genes and of plasmacytoid dendritic cells in HIV-1 positive subjects with GB virus C co-infection.

Authors:  E Lalle; A Sacchi; I Abbate; A Vitale; F Martini; G D'Offizi; G Antonucci; C Castilletti; F Poccia; M R Capobianchi
Journal:  Int J Immunopathol Pharmacol       Date:  2008 Jan-Mar       Impact factor: 3.219

6.  Persistent GB virus C infection and survival in HIV-infected men.

Authors:  Carolyn F Williams; Donna Klinzman; Traci E Yamashita; Jinhua Xiang; Philip M Polgreen; Charles Rinaldo; Chenglong Liu; John Phair; Joseph B Margolick; Dietmar Zdunek; Georg Hess; Jack T Stapleton
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

Review 7.  GB virus infection: a silent anti-HIV panacea within?

Authors:  Esaki Muthu Shankar; Sunil Suhas Solomon; Ramachandran Vignesh; Kailapuri G Murugavel; Muthu Sundaram; Suniti Solomon; Pachamuthu Balakrishnan; Nagalingeswaran Kumarasamy
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-05-29       Impact factor: 2.184

8.  Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis.

Authors:  Padmini Srikantiah; Joseph K Wong; Teri Liegler; Maria Walusimbi; Harriet Mayanja-Kizza; Harriet K Kayanja; Roy D Mugerwa; Edwin D Charlebois; W Henry Boom; Christopher C Whalen; Diane V Havlir
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-01       Impact factor: 3.731

9.  Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model.

Authors:  S E Gabriel; K N Brigman; B H Koller; R C Boucher; M J Stutts
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

10.  An immune basis for malaria protection by the sickle cell trait.

Authors:  Thomas N Williams; Tabitha W Mwangi; David J Roberts; Neal D Alexander; David J Weatherall; Sammy Wambua; Moses Kortok; Robert W Snow; Kevin Marsh
Journal:  PLoS Med       Date:  2005-05-31       Impact factor: 11.069

View more
  5 in total

Review 1.  Role of GB virus C in modulating HIV disease.

Authors:  Carolynne Schwarze-Zander; Jason T Blackard; Juergen K Rockstroh
Journal:  Expert Rev Anti Infect Ther       Date:  2012-05       Impact factor: 5.091

2.  Human pegivirus 1 in Cabo Verde: prevalence and genotypic distribution among HIV-infected individuals.

Authors:  Isabel Inês M de Pina-Araujo; Marco Aurélio Horta; Francisco Campello do Amaral Mello; Caroline Cordeiro Soares
Journal:  Arch Virol       Date:  2021-03-10       Impact factor: 2.574

Review 3.  Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41.

Authors:  Jing Pu; Qian Wang; Wei Xu; Lu Lu; Shibo Jiang
Journal:  Viruses       Date:  2019-08-01       Impact factor: 5.048

4.  A hunter virus that targets both infected cells and HIV free virions: implications for therapy.

Authors:  Cody Greer; Gisela García-Ramos
Journal:  Theor Biol Med Model       Date:  2012-12-06       Impact factor: 2.432

5.  Infection of female primary lower genital tract epithelial cells after natural pseudotyping of HIV-1: possible implications for sexual transmission of HIV-1.

Authors:  Yuyang Tang; Alvin George; Franklin Nouvet; Stephanie Sweet; Nkiruka Emeagwali; Harry E Taylor; Glenn Simmons; James E K Hildreth
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.